Glaucoma News and Research

Latest Glaucoma News and Research

IRIS Registry presents latest eye research at AAO 2022

IRIS Registry presents latest eye research at AAO 2022

The potential of NMR-based blood profiling as a single-domain assay to simultaneously predict multidisease onset

The potential of NMR-based blood profiling as a single-domain assay to simultaneously predict multidisease onset

First multi-center, large-scale registry of severe asthma patients launched in Singapore

First multi-center, large-scale registry of severe asthma patients launched in Singapore

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Father of modern corneal science honored with the 2022 António Champalimaud Vision Award

Exposure to blue light may accelerate aging

Exposure to blue light may accelerate aging

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

Individuals with early-onset diabetes, hypertension more likely to develop primary open-angle glaucoma

Caffeine metabolite could become a valuable treatment for myopia in children

Caffeine metabolite could become a valuable treatment for myopia in children

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

Genetic variant associated with Alzheimer's disease plays a role in protecting against glaucoma

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

Financial incentives from pharma companies can influence how vision care practitioners prescribe branded eyedrops

Study finds high level of resilience among children and adolescents living with glaucoma

Study finds high level of resilience among children and adolescents living with glaucoma

Study uncovers new prognostic marker for multiple sclerosis severity

Study uncovers new prognostic marker for multiple sclerosis severity

New, non-invasive imaging method may help detect an early indicator of glaucoma

New, non-invasive imaging method may help detect an early indicator of glaucoma

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

Black patients have higher risk of advanced vision loss after glaucoma diagnosis compared to whites

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

The interplay of family history and genome-wide polygenic risk scores across 24 common diseases

New resource-light model can identify many common eye diseases

New resource-light model can identify many common eye diseases

RUDN doctors propose an alternative method of surgical management of glaucoma

RUDN doctors propose an alternative method of surgical management of glaucoma

Study: Glaucoma diagnosis not associated with steeper rates of cognitive decline

Study: Glaucoma diagnosis not associated with steeper rates of cognitive decline

A proposal to import drugs from other countries creates an unusual alliance in the Senate

A proposal to import drugs from other countries creates an unusual alliance in the Senate

Stem cell models help determine previously unknown genetic markers of glaucoma

Stem cell models help determine previously unknown genetic markers of glaucoma

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.